Abstract
Demyelination of the cerebellum is a well-known phenomenon in human multiple sclerosis (MS). Concordantly, patients with MS frequently developed symptoms deriving from cerebellar lesions, i.e., dysmetria leading to hand dexterity impairment. Important advances in MS research have been made as a direct or indirect consequence of the establishment of adequate animal models. In this study, we used the cuprizone mouse model to investigate cerebellar demyelination in young adult male mice. The myelin status was analyzed by immunohistochemistry for proteolipoprotein and electron microscopy. The expression and presence of oligodendrocyte, astroglial, and microglia markers were supplementary studied. Cuprizone intoxication induced an almost complete demyelination of cerebellar nuclei. Cerebellar cortex regions were not (cortical gray matter) or only marginally (cortical white matter) affected. In addition, the affected areas displayed hypertrophic and hyperplastic astrocytosis accompanied by microglia or macrophage invasion. We conclude that cuprizone-induced demyelination pictures cerebellar deep gray matter involvement but not cerebellar cortex pathology as described for human MS. Behavioral changes after cuprizone described for this animal model may not only result from effects on commissural fiber tracts but also can arise from cerebellar demyelination.
Similar content being viewed by others
Abbreviations
- APC:
-
adenomatous polyposis coli protein
- CCx:
-
cerebellar cortex
- CM:
-
cerebellar marrow
- CNS:
-
central nervous system
- cuprizone:
-
bis-cyclohexanone oxaldihydrazone
- EAE:
-
experimental autoimmune encephalomyelitis
- GFAP:
-
glial fibrillary acidic protein
- GL:
-
granular layer
- HPRT:
-
hypoxanthine-guanine phosphoribosyltransferase
- Iba-1:
-
ionized calcium binding adaptor molecule
- IHC:
-
immunohistochemistry
- IN:
-
interpositus nucleus
- LCN:
-
lateral cerebellar nucleus
- MBP:
-
myelin basic protein
- MCN:
-
medial cerebellar nucleus
- ML:
-
molecular layer
- MRI:
-
magnet resonance imaging
- MS:
-
multiple sclerosis
- PL:
-
pyramidal layer
- PLP:
-
proteolipoprotein
- rt:
-
reverse transcription
- RT:
-
real time
- WM:
-
white matter
References
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343(13):938–992
Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T (1999) Cortical lesions in multiple sclerosis. Brain 122(Pt 1):17–26
Kutzelnigg A, Lassmann H (2006) Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? J Neurol Sci 245(1–2):123–126
Pokryszko-Dragan A, Gruszka E, Bilinska M, Dubik-Jezierzanska M (2008) Secondary progressive multiple sclerosis - clinical course and potential predictive factors. Neurol Neurochir Pol 42(1):6–11
Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H et al (2007) Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 17(1):38–44
Gilmore CP, Donaldson I, Bo L, Owens T, Lowe JS, Evangelou N (2009) Regional variations in the extent and pattern of grey matter demyelination in Multiple Sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 80(2):182–187
Craner MJ, Lo AC, Black JA, Baker D, Newcombe J, Cuzner ML et al (2003) Annexin II/p11 is up-regulated in Purkinje cells in EAE and MS. Neuroreport 14(4):555–558
Tonra JR (2002) Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy. Cerebellum 1(1):57–68
Yousry TA, Grossman RI, Filippi M (2000) Assessment of posterior fossa damage in MS using MRI. J Neurol Sci 172(Suppl 1):S50–S53
Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, Berente Z, Komoly S, Beyer C (2008) 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia, in press
Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9(11):839–855
Lassmann H, Bruck W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7(3):115–121
Franco-Pons N, Torrente M, Colomina MT, Vilella E (2007) Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Toxicol Lett 169(3):205–213
Liebetanz D, Merkler D (2006) Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp Neurol 202(1):217–224
Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11(1):107–116
Stott SR, Kirik D (2006) Targeted in utero delivery of a retroviral vector for gene transfer in the rodent brain. Eur J Neurosci 24(7):1897–1906
Cao Q, Xu XM, Devries WH, Enzmann GU, Ping P, Tsoulfas P et al (2005) Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 25(30):6947–6957
Tekkok SB, Goldberg MP (2001) Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21(12):4237–4248
Cheung KK, Mok SC, Rezaie P, Chan WY (2008) Dynamic expression of Dab2 in the mouse embryonic central nervous system. BMC Dev Biol 8(1):76
Wells JE, Biernaskie J, Szymanska A, Larsen PH, Yong VW, Corbett D (2005) Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice. Eur J Neurosci 21(1):187–196
Kipp M, Norkute A, Johann S, Lorenz L, Braun A, Hieble A et al (2008) Brain-region-specific astroglial responses in vitro after LPS exposure. J Mol Neurosci 35(2):235–243
Kipp M, Karakaya S, Johann S, Kampmann E, Mey J, Beyer C (2007) Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. J Neuroendocrinol 19(10):819–822
Alusi SH, Worthington J, Glickman S, Bain PG (2001) A study of tremor in multiple sclerosis. Brain 124(Pt 4):720–730
Ito M (2006) Cerebellar circuitry as a neuronal machine. Prog Neurobiol 78(3-5):272–303
Schwarz C, Thier P (1999) Binding of signals relevant for action: towards a hypothesis of the functional role of the pontine nuclei. Trends Neurosci 22(10):443–451
Mitosek-Szewczyk K, Sulkowski G, Stelmasiak Z, Struzynska L (2008) Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis. Neuroscience 155(1):45–52
Kis B, Rumberg B, Berlit P (2008) Clinical characteristics of patients with late-onset multiple sclerosis. J Neurol 255(5):697–702
Dubois-Dalcq M, Ffrench-Constant C, Franklin RJ (2005) Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48(1):9–12
Torkildsen O, Brunborg LA, Myhr KM, Bo L (2008) The cuprizone model for demyelination. Acta Neurol Scand Suppl 188:72–76
Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F et al (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172(4):1053–1061
Norkute A, Hieble A, Braun A, Johann S, Clarner T, Baumgartner W, Beyer C, Kipp M (2008) Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J Neurosci Res 19
Kleim JA, Pipitone MA, Czerlanis C, Greenough WT (1998) Structural stability within the lateral cerebellar nucleus of the rat following complex motor learning. Neurobiol Learn Mem 69(3):290–306
Alvina K, Walter JT, Kohn A, Ellis-Davies G, Khodakhah K (2008) Questioning the role of rebound firing in the cerebellum. Nat Neurosci 11(11):1256–1258
Sanchez-Campusano R, Gruart A, Delgado-Garcia JM (2007) The cerebellar interpositus nucleus and the dynamic control of learned motor responses. J Neurosci 27(25):6620–6632
Pu YM, Wang JJ, Wang T, Yu QX (1995) Cerebellar interpositus nucleus modulates neuronal activity of lateral hypothalamic area. Neuroreport 6(7):985–988
Aschoff JC, Conrad B, Kornhuber HH (1974) Acquired pendular nystagmus with oscillopsia in multiple sclerosis: a sign of cerebellar nuclei disease. J Neurol Neurosurg Psychiatry 37(5):570–577
Tjoa CW, Benedict RH, Weinstock-Guttman B, Fabiano AJ, Bakshi R (2005) MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 234(1–2):17–24
Li Y, Chiaravalloti ND, Hillary FG, Deluca J, Liu WC, Kalnin AJ et al (2004) Differential cerebellar activation on functional magnetic resonance imaging during working memory performance in persons with multiple sclerosis. Arch Phys Med Rehabil 85(4):635–639
Blakemore WF, Franklin RJ (2008) Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol 318:193–212
Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD (2004) Theiler’s virus infection: a model for multiple sclerosis. Clin Microbiol Rev 17(1):174–207
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707–717
Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55(4):458–468
Ludwin SK, Johnson ES (1981) Evidence for a “dying-back” gliopathy in demyelinating disease. Ann Neurol 9(3):301–305
Komoly S (2005) Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Ideggyogy Sz 58(1–2):40–43
Karakaya S, Kipp M, Beyer C (2007) Oestrogen regulates the expression and function of dopamine transporters in astrocytes of the nigrostriatal system. J Neuroendocrinol 19(9):682–690
Pawlak J, Brito V, Kuppers E, Beyer C (2005) Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res 138(1):1–7
Lassmann H (2008) Models of multiple sclerosis: new insights into pathophysiology and repair. Curr Opin Neurol 21(3):242–247
Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A et al (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366(9485):579–582
Williams A, Piaton G, Lubetzki C (2007) Astrocytes–friends or foes in multiple sclerosis. Glia 55(13):1300–1312
Johann S, Kampmann E, Denecke B, Arnold S, Kipp M, Mey J et al (2008) Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation. J Mol Neurosci 34(2):177–185
Komoly S, Hudson LD, Webster HD, Bondy CA (1992) Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 89(5):1894–1898
Mason JL, Ye P, Suzuki K, D’Ercole AJ, Matsushima GK (2000) Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20(15):5703–5708
McMahon EJ, Suzuki K, Matsushima GK (2002) Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol 130(1–2):32–45
Acknowledgment
We would like to thank U. Zahn, A. Weth and H. Helten for excellence technical assistance. This research project was supported by the START-Program (MK) of the Faculty of Medicine, RWTH Aachen University and seed funds of the RWTH Aachen University (WB).
Author information
Authors and Affiliations
Corresponding author
Additional information
Angela Groebe and Tim Clarner contributed equally to this work.
Rights and permissions
About this article
Cite this article
Groebe, A., Clarner, T., Baumgartner, W. et al. Cuprizone Treatment Induces Distinct Demyelination, Astrocytosis, and Microglia Cell Invasion or Proliferation in the Mouse Cerebellum. Cerebellum 8, 163–174 (2009). https://doi.org/10.1007/s12311-009-0099-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-009-0099-3